Daiichi Sankyo Co Ltd (STU:D4S)
€ 29.4 -0.21 (-0.71%) Market Cap: 55.24 Bil Enterprise Value: 48.46 Bil PE Ratio: 37.21 PB Ratio: 5.53 GF Score: 93/100

Daiichi Sankyo Co Ltd R&D Day Transcript

Dec 19, 2019 / 03:30PM GMT
Release Date Price: €19.17 (-1.69%)
Junichi Onuma
Daiichi Sankyo Company, Limited - VP of Corporate Communications Department

Good morning, ladies and gentlemen. Welcome to Daiichi Sankyo R&D Day. Thank you for your participation today. My name is Junichi Onuma, I am the MC today. Let me introduce our presenters. Our President and CEO, Sunao Manabe; our Global R&D Head, Junichi Koga; our Global Oncology R&D Head, Antoine Yver.

Our presentation will take about 1 hour. After the presentation, we'll answer your question until 12:30. In Q&A session, our Global Head of Oncology Development (inaudible), will also answer the question.

Okay. Now I hand it over to Manabe-san.

Sunao Manabe
Daiichi Sankyo Company, Limited - President, Group CEO & Representative Director

Good morning, ladies and gentlemen. My name is Sunao Manabe, and I'm the President and CEO of Daiichi Sankyo. I would like to thank you for your participation in Daiichi Sankyo's R&D Day.

To begin with, I will explain the strength of Daiichi Sankyo's R&D and share some top line

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot